• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

Using protein structure prediction tools, researchers have uncovered receptor structure-function relationships to improve ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...

Researchers at Columbia University Irving Medical Center have identified the specific neurons in mice brains that tell them ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Haley Sipes lost 75 pounds over 10 months with diet and exercise alone. On TikTok, where the 31-year-old mother of three chronicled her weight loss journey, commenters speculated that she was using ...

The NHS had been facing supply issues with glucagon-like peptide receptor agonists (GLP-1 RAs, or GLP-1 analogues), a range of drugs used for managing blood glucose levels in people with type 2 ...

A synapse is the space between the axon of one neuron and the dendrites of another, and receptors are proteins that receive neurotransmitters at the synapse Royalty-free licenses let you pay once to ...

The Science Illustration Internship is a full-time program (40 hours/week) for nine weeks (with a possible 10th week, if needed for any certifications), from June 2nd - August 1st, 2025 (Please note ...

Background: Despite their potential, Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have not been well studied in cardiac amyloidosis (CA) as randomized trials on GLP-1 RA have excluded patients ...

We reviewed the best free Adobe Illustrator alternatives for managing graphics files without a Creative Cloud subscription. We've rounded-up our top-rated choices for when you want to make the ...

For more information about INDIGO's GLP-1R, GIPR, and Glucagon Receptor Reporter Assays and other products and services, visit ...